Current funding for the Sengupta Lab includes:
2014 – 2018 K08 NS083626
Title: Elucidating Signaling Pathways for GABAA Receptor alpha5 in an Aggressive Subtype of Medulloblastomas.
2017 – 2018 Winship Cancer Institute #IRG-14-188-01 from the American Cancer Society
Title: Targeting medulloblastoma with benzodiazepines delivered using tunable biodegradable hydrogels.
2017 B*CURED Clinical Research Investigator Award
Title: Radio sensitization of Group 3 Medulloblastoma with Benzodiazepines